Role of GDF-15 in diabetic nephropathy: mechanisms, diagnosis, and therapeutic potential

被引:1
|
作者
Zhang, Xin [1 ]
Zhou, Chen-gang [1 ]
Ma, Li-jia [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Clin Lab, Shanghai 201100, Peoples R China
[2] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Pathol Dept, Shanghai 201100, Peoples R China
关键词
Circulating growth differentiation factor 15; Diabetic nephropathy; Progression; DIFFERENTIATION FACTOR 15; PROGNOSIS; FACTOR-15; BIOMARKER; TYPE-1; IDENTIFICATION; MORTALITY; CYTOKINE; CACHEXIA; PATHWAY;
D O I
10.1007/s11255-024-04179-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
PurposeGrowth differentiation factor 15 (GDF-15) is a cytokine involved in regulating homeostasis, and its expression is up-regulated in response to injury, stress, and inflammation. This study explored the role of GDF-15 in diabetic nephropathy (DN), a severe complication of diabetes mellitus, and its potential as a biomarker for disease progression.MethodsAs a member of the transforming growth factor-beta superfamily, GDF-15 exhibits its renal protective functions primarily through its anti-inflammatory effects and the up-regulation of other renal protective factors. This study evaluated the association between circulating GDF-15 levels and DN progression, examining the underlying mechanisms.ResultsCirculating GDF-15 levels are closely linked to the development and progression of DN. While existing research has yielded some consistent conclusions, a comprehensive understanding of the role of GDF-15 in DN pathogenesis is needed to identify new therapeutic targets and strategies.ConclusionGDF-15 has the potential to be a prognostic and diagnostic biomarker for DN. It is crucial to establish appropriate reference ranges and explore their clinical utility in routine practice for validating the role of GDF-15 in DN management. Further interventional studies are required to confirm its clinical value in diagnosing and predicting the progression of DN.
引用
收藏
页码:169 / 175
页数:7
相关论文
共 50 条
  • [21] Therapeutic potential of angiostatin in diabetic nephropathy
    Zhang, SX
    Wang, JJ
    Lu, K
    Mott, R
    Ma, JX
    DIABETES, 2005, 54 : A211 - A211
  • [22] Fibrates: Therapeutic potential for diabetic nephropathy?
    Kouroumichakis, I.
    Papanas, N.
    Zarogoulidis, P.
    Liakopoulos, V.
    Maltezos, E.
    Mikhailidis, D. P.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (04) : 309 - 316
  • [23] Therapeutic potential of angiostatin in diabetic nephropathy
    Zhang, Sarah X.
    Wang, Joshua J.
    Lu, Kangmo
    Mott, Robert
    Longeras, Richard
    Ma, Jian-xing
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (02): : 475 - 486
  • [24] GDF-15/GFRAL Axis, Survival, and Kidney Protection in Lipopolysaccharide and Folic Acid Nephropathy in Mice
    Frikke-Schmidt, Henriette
    Meng, Rong
    Ho, George
    Farrington, Krista P.
    Pocai, Alessandro
    Mullican, Shannon
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 372 - 372
  • [25] Growth differentiation factor 15 (GDF-15) as potential cardiovascular risk biomarker in antiphospholipid syndrome
    Tektonidou, Maria G.
    Papassotiriou, Ioannis
    Sfikakis, Petros P.
    RHEUMATOLOGY, 2022, 61 (01) : 394 - 399
  • [26] GDF-15 as a Therapeutic Target of Diabetic Complications Increases the Risk of Gallstone Disease: Mendelian Randomization and Polygenic Risk Score Analysis
    Yu, Lili
    Zhou, Yajing
    Wang, Lijuan
    Zhou, Xuan
    Sun, Jing
    Xiao, Jiarui
    Xu, Xiaolin
    Larsson, Susanna C.
    Yuan, Shuai
    Li, Xue
    FRONTIERS IN GENETICS, 2022, 13
  • [27] Prediction of the molecular mechanisms and potential therapeutic targets for diabetic nephropathy by bioinformatics methods
    Wang, Wan-Ning
    Zhang, Wen-Long
    Zhou, Guang-Yu
    Ma, Fu-Zhe
    Sun, Tao
    Su, Sen-Sen
    Xu, Zhong-Gao
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 37 (05) : 1181 - 1188
  • [28] ROLE OF GROWTH-DIFFERENTIATION FACTOR 15 (GDF-15) IN A MOUSE-MODEL OF ATHEROSCLEROSIS
    Bonaterra, G. A.
    Thogersen, J.
    Zuegel, S.
    Bendner, G.
    Vorwald, S.
    Fey, J.
    Traut, U.
    Strelau, J.
    Kinscherf, R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 96 - 97
  • [29] NAG-1/GDF-15: No evidence for an inhibitory role in colon cancer?
    Zimmers, Teresa A.
    Gutierrez, Juan C.
    Koniaris, Leonidas G.
    GASTROENTEROLOGY, 2007, 132 (03) : 1204 - 1205
  • [30] DIABETIC NEPHROPATHY - MECHANISMS OF PROGRESSION AND THERAPEUTIC POSSIBILITIES
    ROMERO, R
    SALINAS, I
    NEFROLOGIA, 1992, 12 : 54 - 62